Dan Puckett - 12 Jan 2024 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Chief Financial Officer
Signature
s/ Wade Estey, as attorney-in-fact for Dan Puckett
Issuer symbol
N/A
Transactions as of
12 Jan 2024
Net transactions value
-$450,219
Form type
4
Filing time
17 Jan 2024, 20:21:48 UTC
Previous filing
11 Dec 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Award $0 +5,520 +20% $0.000000 33,252 12 Jan 2024 Direct F1
transaction SWAV Common Stock Tax liability $450,219 -2,114 -6.4% $212.97 31,138 17 Jan 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting and settlement of a performance-based restricted stock unit award granted on February 1, 2022, resulting from the achievement of certain performance criteria related to the compound annual growth rate of the Issuers revenue during the measurement period January 1, 2022 through December 31, 2023.